Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

n/a
Article Publish Status: FREE
Abstract Title:

Tanshinone IIA attenuates ovalbumin-induced airway inflammation and hyperresponsiveness in a murine model of asthma.

Abstract Source:

Iran J Basic Med Sci. 2019 Feb ;22(2):160-165. PMID: 30834081

Abstract Author(s):

Shi-Biao Wang, Xiao-Feng Guo, Bin Weng, Su-Ping Tang, Hui-Jie Zhang

Article Affiliation:

Shi-Biao Wang

Abstract:

Objectives: Tanshinone IIA (T. IIA), one of the most pharmacologically active components extracted from, has anti-inflammatory and antioxidant features. The aim of the present study is to investigate the benefit ofon asthma using a murine model of asthma induced by ovalbumin (OVA).

Materials and Methods: Male BALB/c mice were used in the present study. The mice were sensitized by OVA intraperitoneal injection on days 0 and 14, and received aerosolized OVA challenge for 30 min daily on days 21-23. T. IIA (10 mg/kg twice daily) intraperitoneal injection was performed on days 18-23.

Results: Treatment of T. IIA reduced the levels of interleukin (IL)-4, IL-5, and IL-13 in bronchoalveolar lavage fluid (BALF) (<0.05 for all cases). The OVA-induced elevation of total white blood cells as well as differential white blood cells in BALF and blood were inhibited by(<0.05 for all cases). Moreover, airway hyperresponsiveness was dampened in T. IIA-treated group (<0.05). T. IIA inhibited the activation of nuclear factor-κB in asthmatic mice (<0.05). The activity of nuclear factor erythroid-2-related factor 2 was enhanced in T. IIA-treated group (<0.05). T. IIA elevated the activities of heme oxygenase-1, glutathione peroxidase, and superoxide dismutase (<0.05 for all cases).

Conclusion: T. IIA inhibits OVA-induced airway inflammation and hyperresponsiveness. T. IIA is a potential therapeutic agent for asthma.

Study Type : Animal Study
Additional Links
Pharmacological Actions : Anti-Asthmatic Agents : CK(24) : AC(3)

Print Options


Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2019 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.